Colorado § 12-280-405 Prescription drug monitoring fund - creation - fee - repeal

Colorado Statutes

§ 12-280-405 — Prescription drug monitoring fund - creation - fee - repeal

Colorado § 12-280-405

Title 12Professions

Art.Pharmacists, Pharmacy Businesses,

This text of Colorado § 12-280-405 (Prescription drug monitoring fund - creation - fee - repeal) is published on Counsel Stack Legal Research, covering Colorado primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Colo. Rev. Stat. § 12-280-405 (2026).

Text

(1)The board may seek and accept money from any public or private entity for the purposes of implementing and maintaining the program. The board shall transmit any money it receives to the state treasurer, who shall credit the money to the prescription drug monitoring fund, which fund is hereby created. The money in the fund is subject to annual appropriation by the general assembly for the sole purpose of implementing and maintaining the program. The money in the fund must not be transferred to or revert to the general fund at the end of any fiscal year.

(2)Repealed.

(3)If, based upon the appropriations for the direct and indirect costs of the program, there is insufficient money to maintain the program, the division may collect an annual fee of no more than seventeen dolla

Free access — add to your briefcase to read the full text and ask questions with AI

(1)
The board may seek and accept money from any public or private entity for the
purposes of implementing and maintaining the program. The board shall transmit
any money it receives to the state treasurer, who shall credit the money to the
prescription drug monitoring fund, which fund is hereby created. The money in the
fund is subject to annual appropriation by the general assembly for the sole
purpose of implementing and maintaining the program. The money in the fund must
not be transferred to or revert to the general fund at the end of any fiscal year.

(2) Repealed.

(3) If, based upon the appropriations for the direct and indirect costs of the
program, there is insufficient money to maintain the program, the division may
collect an annual fee of no more than seventeen dollars and fifty cents for the
fiscal years 2011-12 and 2012-13, twenty dollars for the fiscal years 2013-14 and
2014-15, and twenty-five dollars for each fiscal year thereafter, from an individual
who holds a license from the division that authorizes him or her to prescribe a
controlled substance, as defined in section 18-18-102 (5). The division shall set the
fee pursuant to section 12-20-105 and shall collect the fee in conjunction with the
license renewal fees collected pursuant to section 12-20-105. Money collected
pursuant to this subsection (3) is credited to the prescription drug monitoring fund
created in subsection (1) of this section.

(4) (a) Notwithstanding subsection (1) of this section, on July 1, 2020, the
state treasurer shall transfer two hundred sixty-seven thousand five hundred
twenty-one dollars from the prescription drug monitoring fund created in
subsection (1) of this section to the general fund.

(b) Notwithstanding any provision of subsection (1) of this section to the
contrary, on June 30, 2025, the state treasurer shall transfer one million seven
hundred fifty thousand dollars from the prescription drug monitoring fund to the
general fund.

(c) This subsection (4) is repealed, effective July 1, 2026.

Legislative History

Source: L. 2019: Entire title R&RE with relocations, (HB 19-1172), ch. 136, p. 1499, � 1, effective October 1. L. 2020: (4) added, (HB 20-1406), ch. 178, p. 811, � 7, effective June 29. L. 2021: (2) repealed, (SB 21-098), ch. 285, p. 1691, � 3, effective July 1. L. 2025: (4) amended, (SB 25-264), ch. 129, p. 500, � 10, effective April 25.